ライフサイエンスコーパス: manufacturing

1 sugar and byproducts severely affect sucrose manufacturing.

2 ste CO(2) and to reduce pollution in polymer manufacturing.

3 complex activities, such as apparel or paper manufacturing.

4 The syntheses are amenable to large scale manufacturing.

5 ent semiconductor foundry protocols for chip manufacturing.

6 ed nanomaterial discovery, optimization, and manufacturing.

7 ns are expanding rapidly enabled by scalable manufacturing.

8 on prototypes that are realized via additive manufacturing.

9 render this reaction amenable to tonne-scale manufacturing.

10 waste and improve sustainability in polymer manufacturing.

11 to processing of nanomaterials and advanced manufacturing.

12 of surfactants and the complexity of device manufacturing.

13 for large-scale, automated cellular therapy manufacturing.

14 broad utility of these catalysts in additive manufacturing.

15 an example of selective single-domain device manufacturing.

16 sectors like aviation, heavy transport, and manufacturing.

17 means of an electric-field-assisted additive manufacturing.

18 osensors with the possibility of large-scale manufacturing.

19 ight the role of nanotechnology and advanced manufacturing.

20 significant role in the field of laser aided manufacturing.

21 id dynamics, mechanical design drafting, and manufacturing.

22 me scaling exponent for other sectors as for manufacturing.

23 /Cas9 disruption of GM-CSF during CAR-T cell manufacturing.

24 in solid-state devices and simplify scalable manufacturing.

25 re becoming increasingly prevalent in modern manufacturing.

26 is to improve the sustainability of chemical manufacturing.

27 g/storage to tissue engineering and additive manufacturing.

28 in pharmaceutical research, development, and manufacturing.

29 nt) steel tailor-designed for laser additive manufacturing.

30 adequately explore its potential is textile manufacturing.

31 ompounds relevant in food chemistry and food manufacturing.

32 lation, analytical modelling, additive layer manufacturing (3D printing) and experimental testing are

33 n of which are now feasible through additive manufacturing (3D printing).

34 luminium alloy in situ during laser additive manufacturing(9).

35 cal carbon dioxide (Sc-CO(2)) technology for manufacturing a "smart" biomaterial scaffold, which reta

36 noic acid (PFOA) was used as a fluoropolymer manufacturing aid at a fluoropolymer production facility

37 nsolidation of the ceramic grains during the manufacturing also promoted fragmentation of the ceramic

38 njugations (bioconjugations) have emerged as manufacturing alternatives.

39 d by laser powder bed fusion (LPBF) additive manufacturing (AM) are being reported at a rapid rate, t

40 Additive manufacturing (AM) enables production of components that

41 In recent years, additive manufacturing (AM) processes have been used to produce c

42 Additive Manufacturing (AM) techniques offer shorter supply chain

43 cles for the widespread adoption of additive manufacturing (AM).

44 iers identified on the demanding path toward manufacturing and adoption of tissue and organ replaceme

45 materials degradation, hindering large-scale manufacturing and applications of sulfide-based solid-st

46 es in <2 weeks, and is applicable for T-cell manufacturing and assay development.

47 use calls for further advances in materials, manufacturing and characterization paradigms, and design

48 ssing PfLSA1 and PfLSAP2 will now proceed to manufacturing and clinical assessment under good manufac

49 The expansion of manufacturing and commercial agriculture alongside rapid

50 ntration is low, which add complexity to the manufacturing and compromises the printing resolution.

51 on path that is synergistic between additive manufacturing and dispersion strengthening, possibly ena

52 ant targets for increasing in vitro platelet manufacturing and for managing quantitative platelet dis

53 Despite using additional energy for machine manufacturing and fuel consumption, the mechanized pract

54 atform must enable rapid discovery, scalable manufacturing and global distribution.

55 In conclusion, on-site manufacturing and infusion of non-cryopreserved LV20.19

56 sential in the development of strategies for manufacturing and maximizing the efficiency of pharmaceu

57 chemicals that are added to plastics during manufacturing and may leach out once they reach the envi

58 n batteries during materials selection, cell manufacturing and operation.

59 A combination of feasible manufacturing and renewable modules can offer an attract

60 ther drug carrier systems, including ease of manufacturing and scale-up to industrial level, higher d

61 ign characteristics owing to advancements in manufacturing and surgical techniques.

62 eby report for the first time on the design, manufacturing and testing of a three-dimensional (3D) ne

63 of this material is instead scrapped during manufacturing and the remainder during fabrication of fi

64 eramic scaffolds were fabricated by additive manufacturing and then modified for pore-wall reinforcem

65 because of their ease of use, lower cost of manufacturing, and access to intracellular targets.

66 second part of this article, key chemistry, manufacturing, and controls (CMC) information is provide

67 database for scientific research, practical manufacturing, and engineering.

68 te element modeling, fabricated via additive manufacturing, and mechanically tested to determine the

69 Global supply networks in agriculture, manufacturing, and services are a defining feature of th

70 printing (3DP) has transformed engineering, manufacturing, and the use of advanced materials due to

71 fication of target cells in cellular therapy manufacturing applications.

72 ced by thermal drawing process, which is the manufacturing approach used in optical fiber fabrication

73 However, conventional manufacturing approaches are hampered by challenges with

74 that cannot be fabricated with conventional manufacturing approaches.

75 cturing methods like multi-material additive manufacturing are enabling realization of multiscale mat

76 ale surface features, which are artifacts of manufacturing, are shown to influence the morphology of

77 stalex meets the main standards required for manufacturing artificial heart valves and has superior m

78 ors (EHMRs), widely used in construction and manufacturing, as an alternative to N95 respirators duri

79 ver, logistical complexity and high costs of manufacturing autologous viral products limit CAR T cell

80 a manufacturable structure, and (3) Digital manufacturing-automated manufacture of the compiled stru

81 CAR T cell product, including variability in manufacturing, availability, and toxicity profiles.

82 tial not only for biopharmaceutical and food manufacturing but also for the understanding of diseases

83 Additive manufacturing by an electron beam is promising to this e

84 utions with Aroclors in most foods and found manufacturing byproduct PCBs, including PCB11, in tilapi

85 developed CRISPR adaptation-mediated library manufacturing (CALM), which turns bacterial cells into "

86 In this study we reveal how additive manufacturing can be leveraged to produce dispersion str

87 lymphoblastic leukemia blasts during CART19 manufacturing can lead to CAR19+ leukemic cells (CARB19)

88 Investments in manufacturing capacity and public-sector delivery system

89 control MPF formation throughout the textile manufacturing chain by using cutting methods which minim

90 tion has remained elusive due to significant manufacturing challenges.

91 e provide novel information on the impact of manufacturing changes on clinical outcomes and report on

92 highly potent peptide microspheres, to minor manufacturing changes.

93 er bed fusion (LPBF) is a method of additive manufacturing characterized by the rapid scanning of a h

94 ultilayer ceramic capacitors fabricated in a manufacturing-compatible process.

95 lications were initially rejected because of manufacturing concerns (four of 36 [11%] with the EMA, s

96 discussed along with FMT donor screening and manufacturing considerations.

97 rcialized tools, with integrated device mass manufacturing cost still not at a competitive level for

98 g to their high photovoltaic efficiency, low manufacturing cost, and flexibility.

99 n be recycled to reduce electronic waste and manufacturing cost.

100 Additive manufacturing currently facilitates new avenues for mate

101 On the basis of their time patterns and manufacturing data, industrial contributions were found

102 g decreased bioefficacy of unused LLINs with manufacturing dates between 2013 and 2019 collected from

103 In contrast, all (100%, n = 25) LLINs with manufacturing dates prior to 2013 are meeting these bioe

104 Manufacturing delays resulted in early termination (376/

105 Given their ease of manufacturing, distribution and administration, these na

106 Whilst being unusual for a manufacturing domain, such additional analysis provides

107 sence of motor vehicle traffic and suspended manufacturing during the coronavirus disease 2019 (COVID

108 manufacturing to improve product quality and manufacturing efficiency.

109 gen display platforms and have launched cGMP manufacturing efforts to advance the SARS-CoV-2-RBD nano

110 rapy, but the cost and rigor associated with manufacturing engineered T cells ex vivo can be prohibit

111 o protein subunit vaccines, there is limited manufacturing expertise for these nucleic-acid-based mod

112 From 1980 to 2017, a fluorochemical manufacturing facility discharged wastewater containing

113 into the Cape Fear River by a fluorochemical manufacturing facility were detected in blood samples fr

114 of index cases.Conclusions: Evaluation of a manufacturing facility with a cluster of workers with re

115 s part of a public health investigation of a manufacturing facility, we performed a cross-sectional s

116 entration detected in a worker in an HFPO-DA manufacturing facility.

117 of the apheresis product improved CAR T-cell manufacturing feasibility as well as heightened inflamma

118 rfaces, while considered a key to design and manufacturing for future applications, has hitherto been

119 icates a way forward for exploiting additive-manufacturing for realising polymer-based acoustic metam

120 sure virtually the same scaling exponent for manufacturing for the 1993 to 2015 period as for the 197

121 fabricate high quality products by additive manufacturing (for example, 3D printing).

122 t occur during the various stages of textile manufacturing: from fiber extrusion to assembly of the f

123 ntaminants (due to the use of dry air as the manufacturing gas of the ozone generator) affected the o

124 l substrates, demonstrating the potential of manufacturing geometrically versatile devices based on n

125 opment processes to support the alignment of manufacturing, global policy, and program implementation

126 Additive manufacturing has enabled the fabrication of materials a

127 analysis of Antibody-Drug Conjugate Payload manufacturing has revealed that the majority of the cost

128 elieve that bio-inspired design and additive manufacturing have been, and will continue to be, import

129 timize the processing parameters of additive manufacturing have shown that it is difficult to alter t

130 Here we report a novel method of manufacturing high-density multiplexed protein microarra

131 MA strategy has significant implications for manufacturing high-performance fibrous platforms to meet

132 These wearable devices require low-cost manufacturing, high reliability, multifunctionality and

133 ign regions in China are concentrated in key manufacturing hubs, including the Yangtze River Delta, P

134 roposed designs, to determine the effects of manufacturing imperfections and to optimise the performa

135 ificant attention for advanced materials and manufacturing in this epochal transition.

136 ogeochemical cycles, play important roles in manufacturing industries and biomedical research, and in

137 The dye and pigment manufacturing industry is one of the most polluting in t

138 of the major challenges faced by the cheese manufacturing industry.

139 The process of manufacturing infant milk formulas (IMFs) involves heat

140 Laser additive manufacturing is attractive for the production of comple

141 vivo, antigen escape and heterogeneity, and manufacturing issues.

142 Since the advent of additive manufacturing, known commonly as 3D printing, this techn

143 ing due to complex electronics requirements, manufacturing limitations, and the increase in viscous d

144 n toxicity caused by upstream extraction and manufacturing linked to technologies such as solar panel

145 mounts of matter, for harvesting energy, for manufacturing materials and for sensing chemical and bio

146 Our approach offers a general way for manufacturing metal matrix composites with high overall

147 First, an additive manufacturing method that exploits the fused-filament (3

148 aser lithography, an emerging micro-additive manufacturing method with unique geometric capabilities

149 By using existing silicon-based manufacturing methodologies, this room-temperature gas s

150 generators (TEGs) fabricated using additive manufacturing methods are attractive because they offer

151 Conventional antibody-drug conjugate (ADC) manufacturing methods are based on the nonselective bioc

152 Advanced manufacturing methods like multi-material additive manuf

153 However, existing manufacturing methods still rely on a multi-step, error-

154 led 3D mesostructures serve as the basis for manufacturing methods that can bypass limitations of con

155 By using 2D manufacturing methods we are able to create actuators th

156 ustrial processes, facilitate new industrial manufacturing methods, and improve biocompatibility in b

157 ands, as well as the evolution of industrial manufacturing methods.

158 re impossible to achieve through traditional manufacturing methods.

159 This method enables the manufacturing of a fully-functional microfluidic device

160 t fascinate humanity, inspiring an unceasing manufacturing of a kaleidoscopic variety of dyes and pig

161 actices such as sandblasting denim jeans and manufacturing of artificial stone benchtops has led to r

162 in terms of bioprinting technologies for the manufacturing of cellular constructs with particular emp

163 3D printing can allow for the efficient manufacturing of elaborate structures difficult to reali

164 To guide manufacturing of electrode architectures, in-situ X-ray

165 fast prototyping and potentially large-scale manufacturing of functional devices.

166 Conventional manufacturing of glass microfluidic devices is a complex

167 ns using LLZO which may guide the design and manufacturing of high energy density solid-state batteri

168 is approach a promising route for the facile manufacturing of high-performance electrodes at large in

169 offers a viable strategy for the continuous manufacturing of hollow HEA nanomaterials that can find

170 of bioinks have been developed, allowing the manufacturing of in vitro models and implants tested pre

171 rning method provides a new way for additive manufacturing of integrated optoelectronic devices using

172 Additionally, efforts to develop sustainable manufacturing of lithium ion batteries are still lacking

173 The 3D printing allows easy manufacturing of MALDI targets with different dimensions

174 egacy chemicals used in firefighting and the manufacturing of many industrial and consumer goods, are

175 and multilayered structures, and integrated manufacturing of materials for coupled mechanical and fu

176 igh temperature alloy melts is important for manufacturing of metallic components but extremely chall

177 This work points towards single step manufacturing of microstructured fibers using a wide var

178 here pave the way for the versatile additive manufacturing of molecular ferroelectric metamaterials.

179 The sustainable manufacturing of nanoparticles (NPs) has become critical

180 layers during processing is critical for the manufacturing of optoelectronics.

181 utomated fast-flow instrument for the direct manufacturing of peptide chains up to 164 amino acids lo

182 duction attributes and is currently used for manufacturing of several therapeutic proteins and viral

183 applications include material processing and manufacturing of small and large engineering components

184 T cell activation is a cornerstone in manufacturing of T cell-based therapies, and precise con

185 (API) down to 1% w/w during a semicontinuous manufacturing of tablets.

186 Additive manufacturing of TEGs requires active thermoelectric par

187 pendent electrical signal input, the present manufacturing of the array limited the number of effecti

188 with the vast amount of generated data, and manufacturing of the electrode array itself.

189 However, scalable manufacturing of the required complex micromaterials rem

190 on is prolific as a result of the widespread manufacturing of these compounds and their chemical pers

191 gration unlocks the potential of large-scale manufacturing of these integrated systems with low cost

192 s of processing - pasteurization and yoghurt manufacturing - on some health-promoting lipidome compon

193 sufficient to use the recovered lactose from manufacturing operations.

194 where often molten wax is used; in additive manufacturing or metal-production processes; or in extre

195 th the potential to transform medical device manufacturing, organ replacement, and the treatment of d

196 academia; contract research, development and manufacturing organizations; and the pharmaceutical indu

197 ee-dimensional (3D) printing is transforming manufacturing paradigms within healthcare.

198 To advance the considerations on manufacturing parameter dominance, both study design and

199 sin-based cleavage reaction is necessary for manufacturing peptides using rDNA technology with tandem

200 Additive manufacturing permits innovative soft device architectur

201 emical variability can present challenges to manufacturing personalized cancer vaccines in an optimal

202 ucose to fructose is a critical step towards manufacturing petroleum-free chemicals from lignocellulo

203 Electrospinning is an appealing manufacturing platform for GDIs, as it allows for incorp

204 ps that are not directly scalable to current manufacturing platforms.

205 pendent lots of clinical material under good manufacturing practice (GMP) conditions.

206 facturing and clinical assessment under good manufacturing practice (GMP) guidelines.

207 d MSCs) is produced using an optimized, good manufacturing practice (GMP)-compliant manufacturing pro

208 Following in vitro expansion using a good manufacturing practice-compliant methodology (designed t

209 erapies that could be integrated into a good manufacturing practice-compliant process.

210 d to develop a simple, fully automated, good-manufacturing-practice (GMP)-compliant production proced

211 lf-life of (64)Cu would also facilitate good-manufacturing-practice production and distribution to si

212 erview of this complex field of current good manufacturing practices (cGMP) based on biopharmaceutica

213 blood or leukapheresis, expanded under good manufacturing practices (GMP) conditions, and administer

214 C) closer to a possible validation in a Good Manufacturing Practices (GMP) environment.

215 dose of a cell-based, reverse-genetics, Good Manufacturing Practices-produced wild-type influenza A(H

216 al co-delivery of miR-18a and NEO100, a good manufacturing practices-quality form of perillyl alcohol

217 ntrinsic materials solution, without complex manufacturing procedure or much increased fabrication co

218 cteristics that must be monitored during the manufacturing process and subsequent quality control ass

219 t and reliable monitoring of PTMs during the manufacturing process for both bioreactor control or as

220 aquinone were determined at each step of the manufacturing process for green and black tea using gas

221 during the directed energy deposition (DED) manufacturing process of a 7075-Al alloy part.

222 of whisky and the impact of each step in the manufacturing process provides a basis for responding to

223 f parameters in the formulation composition, manufacturing process, and characterization of micropart

224 mitigate protein degradation during the drug manufacturing process, storage, and transportation.

225 acterization and close monitoring during the manufacturing process.

226 us variables involved in the composition and manufacturing process.

227 that are fast, applicable in situ and to the manufacturing process.

228 d possibly indicate contamination during the manufacturing process.

229 ation of the formulation composition and the manufacturing process.

230 good manufacturing practice (GMP)-compliant manufacturing process.

231 rations associated with large-scale additive manufacturing processes (3D printing).

232 o a drug product compliant with current good manufacturing processes (cGMPs).

233 Excellent reliability of the manufacturing processes and low cost have drawn ever inc

234 The composition of the formulation and the manufacturing processes determine the essential property

235 is challenging the dominance of conventional manufacturing processes for products with high complexit

236 Additive manufacturing processes used to create regenerative bone

237 ize 3D printers, in this case large additive manufacturing processes using acrylonitrile-butadiene-st

238 Products, feedstocks, and manufacturing processes will need to integrate the princ

239 and new drug products leading to continuous manufacturing processes, and personalized medicine.

240 orm further evaluation of product design and manufacturing processes, including quantification of met

241 rogels and hydrophobic elastomers-in various manufacturing processes-with strong, stretchable, and tr

242 ation-hardened alloys and different additive manufacturing processes.

243 he extensive experience regarding industrial manufacturing processes.

244 reduced productivity in therapeutic antibody manufacturing processes.

245 baseline metrics for current oligonucleotide manufacturing processes.

246 Additive manufacturing promises a major transformation of the pro

247 ce our modifications do not impose intricate manufacturing, require long post-processing, nor sacrifi

248 ithout the design constraints of traditional manufacturing routes.

249 In addition, the established clinical manufacturing, safety and efficacy of blank sHDL nanopar

250 ate the risks of water shortages on the U.S. manufacturing sector.

251 nsport, and materials, a 50-52% reduction in manufacturing, services, and buildings, and a 39% reduct

252 P receiving wastewater from a pharmaceutical manufacturing site, (i) 10 times as many potential indus

253 logistical challenges in material sourcing, manufacturing, standardization and transportation.

254 ncluding, its chemical composition, rigorous manufacturing standards, and ability to target and trans

255 alyzed to study the effect of aging time and manufacturing steps (filtration, addition of additives o

256 annot be removed in the subsequent chocolate-manufacturing steps.

257 and ongoing technical challenges related to manufacturing, storage, transport, and external noninvas

258 autologous cell replacement to be effective, manufacturing strategies will need to change.

259 es of these undercut MNAs and the associated manufacturing strategy, which is compatible with diverse

260 ional, state, and county-levels by each U.S. manufacturing subsector is estimated.

261 By manufacturing sufficiently smaller pores, each tRNA is r

262 Facilities involved in manufacturing suspect products were inspected to assess

263 ion method for metal droplets in an advanced manufacturing system.

264 monitoring of liquid metal jetting additive manufacturing systems.

265 The aim of this study is to describe the manufacturing technique and to assess the preliminary re

266 st time to expand the capability of additive manufacturing technique for creating components with bro

267 l, this work establishes a scalable additive manufacturing technique that enables the integration of

268 3D printing technology has become a mature manufacturing technique, widely used for its advantages

269 sed deposition modeling (FDM) based additive manufacturing technique.

270 From several promising 3D manufacturing techniques for realizing different classes

271 of the design and integration strategies and manufacturing techniques for such sensing systems is giv

272 Three-dimensional bioprinting uses additive manufacturing techniques for the automated fabrication o

273 Lately, additive manufacturing techniques have made a number of designs w

274 nowires are beyond the capability of current manufacturing techniques, which impose limitations on th

275 materials are in demand for modern additive manufacturing techniques, while preliminary tests have a

276 lumes that stem from limitations in additive manufacturing techniques.

277 thus limiting their processing via additive manufacturing techniques.

278 o conventional fabrics using typical textile manufacturing techniques.

279 ue advantages that they and their associated manufacturing technologies have offered.

280 al biosensors constructed with semiconductor manufacturing technology (SMT)-produced electrodes and a

281 Over the last decades, advancements in manufacturing technology, computational tools, and synth

282 r developing the next generation of additive manufacturing technology.

283 extiles, utilizing a fundamentally different manufacturing technology.

284 Manufacturing the kit in larger quantities could reduce

285 Conductive inks, necessary for manufacturing the next generation diagnostic devices, cu

286 printing, and the large build space provides manufacturing throughput, while FFF offers a great selec

287 and modified by either bottom-up or top-down manufacturing to enable different functions for water fi

288 ithography is currently entering high-volume manufacturing to enable the continued miniaturization of

289 microstructure, paving the way for additive manufacturing to repair, restore, and reshape any supera

290 9 CAR T cells and the feasibility of on-site manufacturing using the CliniMACS Prodigy system.

291 we show the potential for "Li-free" battery manufacturing using the Li(7)La(3)Zr(2)O(12) (LLZO) elec

292 Volumetric additive manufacturing (VAM) forms complete 3D objects in a singl

293 Cell manufacturing was set at 14 d with the goal of infusing

294 Deep decarbonization of cement manufacturing will require remediation of both the CO(2)

295 nanophotonics, which can guide silicon color manufacturing with high accuracy.

296 In particular, additive manufacturing with two-photon polymerization allows crea

297 fect of these minority phases was avoided by manufacturing, with the help of focused-ion-beam, a mum-

298 hanically-strong biomaterial combined during manufacturing would replace injectable defect fillers (c

299 t metal 3D printers promise to revolutionize manufacturing, yet they have not reached optimal operati

300 apita, recycling rate, product lifespan, and manufacturing yield) in a dynamic material flow analysis